The Role of Mitochondria in Metabolic Health and Disease

A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Cell Metabolism".

Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 5452

Special Issue Editors


E-Mail Website
Guest Editor
Wonju College of Medicine, Yonsei University, Wonju, Korea
Interests: diabetes; metabolic syndrome; mitochondrial calcium uniporter; metabolism physiology; beta-cell physiology; calcium/phosphate regulation

E-Mail Website
Guest Editor
Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Chung-Ang University, Seoul 156-755, Republic of Korea
Interests: insulin signaling; diabetes; cardiovascular disease; endothelium; heart
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Physiology, Ajou University School of Medicine, Suwon, Korea
Interests: mitochondrial metabolism; cardiac metabolism; diabetes; mitochondrial biogenesis; mitochondrial gene expression; glucose metabolism

Special Issue Information

Dear Colleagues,

Mitochondria play essential roles in bioenergetics, redox balance, metabolic flexibility, Ca2+ homeostasis, cell signaling, immunity, growth, development, and cell death. Accordingly, mitochondria are critical for providing resistance to cell stressors, diseases, and senescence. However, mitochondrial dysfunction is a common pathophysiologic process in various conditions, such as metabolic syndrome, neurodegenerative diseases, cardiovascular diseases, cancer, and age-related diseases. Accumulating evidence suggests that the restoration of mitochondrial functions, e.g., by improving mitochondrial metabolism and suppressing oxidative stress, could be a therapeutic target for chronic diseases, such as those listed above. However, the molecular mechanisms related to the pathogenic progression of mitochondrial dysfunction remain to be clearly identified.

This Special Issue is dedicated to recent advances in the role of mitochondria in physiologic regulation, pathophysiologic alterations, and the development of mitochondrially related therapeutic strategies against chronic metabolic diseases and age-related diseases. We will consider original research articles, concept papers, short communications, and reviews on all aspects of mitochondrial biology, pathophysiology, and clinical applications. We hope that this Special Issue will contribute to advancing this fascinating field.

Prof. Dr. Kyu-Sang Park
Prof. Dr. Jaetaek Kim
Prof. Dr. Chan Bae Park
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mitochondrial metabolism
  • mitochondrial morphodynamics
  • mitochondrial biogenesis
  • mitochondrial stress response and mitohormesis
  • mitochondrial oxidative stress
  • mitophagy and quality control
  • mitochondrial gene expression
  • mitochondrial dysfunction
  • mitochondrial diseases
  • metabolic syndrome
  • neurodegenerative diseases
  • cardiovascular disease
  • mitochondrial pathophysiology

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

32 pages, 893 KiB  
Review
Neurodegeneration, Mitochondria, and Antibiotics
by Juan M. Suárez-Rivero, Juan López-Pérez, Inés Muela-Zarzuela, Carmen Pastor-Maldonado, Paula Cilleros-Holgado, David Gómez-Fernández, Mónica Álvarez-Córdoba, Manuel Munuera-Cabeza, Marta Talaverón-Rey, Suleva Povea-Cabello, Alejandra Suárez-Carrillo, Rocío Piñero-Pérez, Diana Reche-López, José M. Romero-Domínguez and José Antonio Sánchez-Alcázar
Metabolites 2023, 13(3), 416; https://doi.org/10.3390/metabo13030416 - 12 Mar 2023
Cited by 1 | Viewed by 2266
Abstract
Neurodegenerative diseases are characterized by the progressive loss of neurons, synapses, dendrites, and myelin in the central and/or peripheral nervous system. Actual therapeutic options for patients are scarce and merely palliative. Although they affect millions of patients worldwide, the molecular mechanisms underlying these [...] Read more.
Neurodegenerative diseases are characterized by the progressive loss of neurons, synapses, dendrites, and myelin in the central and/or peripheral nervous system. Actual therapeutic options for patients are scarce and merely palliative. Although they affect millions of patients worldwide, the molecular mechanisms underlying these conditions remain unclear. Mitochondrial dysfunction is generally found in neurodegenerative diseases and is believed to be involved in the pathomechanisms of these disorders. Therefore, therapies aiming to improve mitochondrial function are promising approaches for neurodegeneration. Although mitochondrial-targeted treatments are limited, new research findings have unraveled the therapeutic potential of several groups of antibiotics. These drugs possess pleiotropic effects beyond their anti-microbial activity, such as anti-inflammatory or mitochondrial enhancer function. In this review, we will discuss the controversial use of antibiotics as potential therapies in neurodegenerative diseases. Full article
(This article belongs to the Special Issue The Role of Mitochondria in Metabolic Health and Disease)
Show Figures

Figure 1

10 pages, 1462 KiB  
Review
Impact of Micro- and Nanoplastics on Mitochondria
by Seung Eun Lee, Yoojung Yi, Sangji Moon, Hyunkyung Yoon and Yong Seek Park
Metabolites 2022, 12(10), 897; https://doi.org/10.3390/metabo12100897 - 23 Sep 2022
Cited by 15 | Viewed by 2588
Abstract
Mitochondria are highly dynamic cellular organelles that perform crucial functions such as respiration, energy production, metabolism, and cell fate decisions. Mitochondrial damage and dysfunction critically lead to the pathogenesis of various diseases including cancer, diabetes, and neurodegenerative and cardiovascular disorders. Mitochondrial damage in [...] Read more.
Mitochondria are highly dynamic cellular organelles that perform crucial functions such as respiration, energy production, metabolism, and cell fate decisions. Mitochondrial damage and dysfunction critically lead to the pathogenesis of various diseases including cancer, diabetes, and neurodegenerative and cardiovascular disorders. Mitochondrial damage in response to environmental contaminant exposure and its association with the pathogenesis of diseases has also been reported. Recently, persistent pollutants, such as micro- and nanoplastics, have become growing global environmental threats with potential health risks. In this review, we discuss the impact of micro- and nanoplastics on mitochondria and review current knowledge in this field. Full article
(This article belongs to the Special Issue The Role of Mitochondria in Metabolic Health and Disease)
Show Figures

Figure 1

Back to TopTop